Walgreens Boots Alliance Stock (NASDAQ: WBA)

Dernières nouvelles pour Walgreens Boots Alliance (NASDAQ:WBA) Stock

WALGREENS BOOTS ALLIANCE INC

Walgreens Boots Alliance

Walgreens Boots Alliance is one of the largest retail pharmacy chains in the US, with over 8,000 locations. Nearly three quarters of Americans live within five miles of a Walgreens location. Roughly two thirds of revenue is generated from prescription drug sales; Walgreens makes up 20% of total prescription revenue in the US. Walgreens also generates sales from retail products (general wellness consumables and its own branded merchandise), European drug wholesale, and healthcare. With more locations incorporating additional services like Health Corner and Village Medical, Walgreens creates an omnichannel experience for patients and positions itself as a one-stop healthcare provider.

Walgreens Boots Alliance, Inc. - Common Stock

Walgreens Boots Alliance Inc

WisdomTree Trust WisdomTree Battery Value Chain and Innovation Fund

The U.S. markets will be closed on Thursday, June 19, in observance of Juneteenth National Independence Day, a federal holiday commemorating the end of slavery in the United States.
What Happened: According to the guidance from the Securities Industry and Financial Markets Association, the New York Stock Exchange and the Nasdaq will both suspend trading for the day, along with the U.S. bond market, which will also remain closed. Trading will resume as normal on Friday, June 20.
Juneteenth is the newest federal holiday in the calendar, having been designated only in 2021 by former President Joe Biden, 156 years after Major General Gordon Granger ordered the final enforcement of the Emancipation Proclamation in Texas on June 19, 1865.
See Also: <a href="https://www.benzinga.com/news/politics/25/06/46010064/ayatollah-assassination-discussion-rejected-by-putin-i-do-not-even-want-to-discuss-this-possibility">Ayatollah Assassination Discussion Rejected By Putin: &#8216;I Do Not Even Want To Discuss This Possibility&#8217;</a>
The decision to make this a national holiday was undertaken following <a href="https://www.benzinga.com/news/24/06/39397814/is-the-market-open-on-juneteenth">months of widespread protests</a> against racial injustice and inequality in 2020. 
While financial markets will be off on Thursday, not all sectors will stop functioning. Most federal government offices, bank branches, schools, and even the U.S. Postal Service will be shutting down, with many state and local government offices also observing the holiday.
Private companies, however, aren&#8217;t required by law to close for federal holidays, and retailers such as Walmart Inc. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/WMT#NYSE">WMT</a>), Target Corp. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/TGT#NYSE">TGT</a>), and Walgreens Boots Alliance Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/WBA#NASDAQ">WBA</a>) will continue <a href="https://edition.cnn.com/2025/06/18/business/open-closed-juneteenth">to</a> remain open during their normal working hours. 
Major banks such as JPMorgan Chase &amp; Co. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/JPM#NYSE">JPM</a>) and Bank of America Corp. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/BAC#NYSE">BAC</a>), among others, will be closed, while online banking and ATMs will continue to function. 
Why It Matters: For years, Juneteenth celebrations were <a href="https://www.benzinga.com/news/22/06/27699154/juneteenth-2022-whats-open-whats-closed-and-what-is-the-holiday-all-about-1">restricted only to Texas</a>, but following the unrest that stemmed from the death of George Floyd in 2020, there were growing calls for making it a nationwide holiday.
Besides Juneteenth, the markets remain closed for <a href="https://www.benzinga.com/money/stock-market-holidays">eight other federal holidays</a>, with the following occasions in the coming months,
<ul class="wp-block-list">
<li>Friday, July 4th—Independence Day</li>
<li>Friday, September 5th—Labor Day</li>
<li>Monday, November 24th—Thanksgiving</li>
<li>Friday, December 26th—Christmas Day</li>
</ul>
Photo Courtesy: iHumnoi on Shutterstock.com Read More: 
<ul class="wp-block-list">
<li><a href="https://www.benzinga.com/crypto/cryptocurrency/25/06/46010451/peter-schiff-doesnt-think-stablecoins-will-help-preserve-dollar-dominance-heres-what-the-economist-says-theyll-do-instead">Peter Schiff Doesn&#8217;t Think Stablecoins Will Help Preserve Dollar Dominance — Here&#8217;s What The Economist Says They&#8217;ll Do Instead</a></li>
</ul>

News

Markets

Are Markets Open On Juneteenth This Year? Here's What's Open And What's Closed On June 19

The best investments you will ever make in your entire life are those in sectors and opportunities where almost nobody else agrees with you.
The consensus holds that the asset class you are reviewing is terrible and investing there will almost certainly lead to immediate and severe loss of funds.
Right at this moment, as we survey Wall Street and Main Street, it is probably easier to find eight-year-old kids looking forward to a dinner of liver and onions with chicken gizzards and broccoli than openly enthusiastic advocates of investing in commercial real estate.
When you take an asset class this universally hated and discover that only private equity professionals truly love it, I start to get interested.
Recently, KKR &amp; Co (Ticker: KKR) came out and waxed poetic about opportunities in commercial real estate debt, pointing out severe price contractions. Low prices tend to bring out buyers and dealmakers, exactly what we are seeing.
John Gray at Blackstone (Ticker: BX) has emerged as a vocal advocate, pounding the table that this is the time to be opportunistic and aggressive. Gray came up through Blackstone&#8217;s real estate division and knows these markets intimately. His firm has generated tremendous returns for themselves and investors in commercial real estate.
When the best minds in private equity begin to pick at and nibble around a sector, it is generally time to start getting interested.
When I examine commercial real estate, offices immediately come to mind. The conventional wisdom holds that offices are empty, and nobody will ever work in them again. People envision office space as something from a post-apocalyptic movie.
In a word, bleak.
The forecast appears terrible.
Workers want to stay home in their sweatpants with dress shirts and ties for Zoom (Ticker: ZM) calls.
That paradigm is shifting. We have completed our work-from-home experiment. The office decline is beginning to ebb, stabilizing at a new, lower baseline.
Across the country, return-to-work policies are emerging. Financial services led the charge. The federal government has made it official policy. State and local governments are following suit.
Artificial intelligence companies are mandating office returns, recognizing that breakthrough innovation requires massive collaborative efforts that demand physical presence.
Return-to-work mandates represent just one factor.
Construction has virtually stopped. Even developers interested in office construction cannot secure financing for new projects.
According to a recent CBRE Group (Ticker: CBRE) report, the math has fundamentally shifted. The combined number of office conversions, to life science buildings, medical facilities, condominiums, and residential buildings, plus outright demolitions exceeds new supply coming to market in many U.S. markets.
We are witnessing the creation of a supply-constrained office market, particularly for Class A space where everyone wants to locate.
Within just a few years, we will face a supply-and-demand imbalance resulting in an actual shortage of high-end Class A office space.
This trend is emerging everywhere, even in battered markets like San Francisco. There, AI-related office space has grown fivefold over recent years and is projected to triple again over the next five years.
&nbsp;Demand is building while new supply remains nonexistent. Office real estate is beginning to improve, yet nobody is paying attention.
For three to four years running, I have heard predictions that multifamily real estate will collapse. These forecasts began with the initial post-pandemic surge that elevated multifamily values.
The reality is we face a massive affordability crisis in residential real estate. Three factors have created a perfect storm: older homeowners with no intention of moving, persistently high mortgage rates, and builders correctly focused on higher-margin market segments.
This combination has eliminated supply at the market&#8217;s lower end.
Estimates of the housing shortage range from two million to six million units, with the true number likely between four and five million.
We face an absolute shortage of new single-family and attached homes (think townhouses rather than condominiums).
Substantial new supply will not come online until older homeowners who own much of existing inventory either pass away or are convinced by their children to relocate. Something must break this logjam.
The mathematics are stark: older homeowners hold mortgages below four percent, creating zero incentive to sell and generate new inventory.
New construction requires tax and economic incentives to make first-time and move-up home building financially viable for developers. That relief remains distant.
The Mortgage Brokers Association forecasts no significant pickup in single-family housing activity over the next several years, nor any meaningful decline in mortgage rates.
Paradoxically, if mortgage rates do fall meaningfully, it will signal that economic activity has ground to a halt, creating different affordability problems entirely.
This dynamic sustains strong multifamily demand. An entire demographic cohort that would typically have purchased homes remains trapped in apartments.
These demographic shifts are creating apartment demand surges. The substantial building wave over recent years to meet post-COVID demand filled immediately upon completion. Construction is decelerating as financing becomes more selective. Lenders will only finance the best apartment complexes in the hottest, highest-end markets.
This pullback makes multifamily commercial real estate particularly attractive, especially if acquired during broader market sell-offs.
Logistics and industrial real estate has emerged as the hottest market, driven by global supply chain restructuring and e-commerce growth. Warehousing has migrated from central districts to locations closer to cities and towns.
&nbsp;Currently, everyone is holding their breath over trade uncertainties and their potential impact on global logistics and supply chains.
This too shall pass.
The underlying demand remains robust. While we experienced a supply surge as supply chains were remade following early COVID disruptions, that wave is now ebbing.
Demand has remained strong, existing supply is filling up, and occupancy rates are very high. The outlook for industrial and logistics real estate remains very positive.
Retail properties present a bifurcated market similar to office real estate. Second and third-tier malls are finished, destined for the dustbin of history. However, Class A malls with premier tenants, exceptional entertainment and dining options, and high-end retail remain fantastic businesses.
Outlet malls continue to thrive.
Open-air centers that are internet-resistant featuring grocery stores, gyms, medical offices, and pharmacies are performing exceptionally well.
Single-tenant net lease retail properties represent another compelling opportunity. These include Walgreens(Ticker: WBA), Starbucks (Ticker: SBUX), Home Depot (Ticker: HD), Walmart (Ticker: WMT), McDonald&#8217;s (Ticker: MCD), Burger King (Ticker: QSR), and other standalone businesses.
When you examine the four corners of any major city intersection, those corner buildings typically house net lease, single-tenant real estate. This is one of my favorite segments of the real estate market and a fantastic business model.
Most commercial real estate sectors are performing well. The only serious problems have been concentrated in downtown office buildings, and even there, the combination of constrained new supply, return-to-work mandates, conversions, and demolitions is generating meaningful market improvement.
This presents an opportune time to consider commercial real estate investments: direct property ownership, commercial real estate companies, servicing companies, and non-REIT companies that own real estate assets. Real opportunity exists here because no one on Wall Street that I am aware of is advocating for commercial real estate and commercial real estate services. Numerous companies are flying well under the radar, potentially offering huge long-term returns for patient, aggressive investors willing to step into the liver and onions of current financial markets.
FRP Holdings (Ticker: FRPH) embodies everything I discussed about commercial real estate opportunities. This Jacksonville, Florida-based holding company operates across four distinct segments that perfectly capture the themes I believe are driving the commercial real estate renaissance: Industrial and Commercial properties, Mining Royalty Lands, Development, and Multifamily residential.
The crown jewel of FRP Holding's portfolio remains largely invisible to most investors.
It is approximately 16,650 acres under lease for mining rents or royalties and an additional 4,280 acres through its Brooksville joint venture with Vulcan Materials. These properties contain reserves totaling over 500 million tons, representing decades of steady cash flow.
I find the mining segment particularly attractive because it brings in approximately $10 million annually in revenue with roughly 90% free cash flow margin, generating $9 million in free cash flow.
Think about that mathematics for a moment. &nbsp;
This represents the purest form of real estate investment, land that generates income without the headaches of tenant management, building maintenance, or capital expenditure cycles. The mining royalty business provides FRP Holdings with a steady foundation of cash flow that supports their more aggressive development activities.
I also like FRP Holding's multifamily portfolio concentration in the Washington D.C. market, exactly where I want exposure as a real estate investor. D.C. is fairly recession-resistant since the federal government is the biggest employer in the area.
The company owns interests in multiple apartment complexes including Dock 79, The Maren, The Verge, Bryant Street, and .408 Jackson through joint ventures.
The strategic positioning becomes clear when you examine FRP Holding's development pipeline. The company has executed an agreement with Steuart Investment Company and MidAtlantic Realty Partners for the development of up to ten mixed-use projects in the Capitol Riverfront and Buzzard Point submarkets of Washington, D.C.
&nbsp;Upon completion and stabilization, these projects will comprise over 3 million square feet of mixed-use development including 3,000 residential units and 150,000 square feet of retail.
I see FRP Holding's industrial segment perfectly capturing the trends I discussed earlier about logistics and warehousing demand.
The company entered into two new joint venture agreements in early 2024 with Altman Logistics. The first joint venture is a 200,000 square-foot warehouse development project in Lakeland, FL, and the second joint venture is a 182,000 square-foot warehouse redevelopment project in Broward County, FL.
Shell construction on their spec warehouse project in Aberdeen, MD on Chelsea Road was completed effective April 1, 2025, and is in the lease-up phase.
&nbsp;This 258,000 square-foot industrial asset in Harford County, Maryland represents exactly the type of modern logistics facility that companies need as they restructure supply chains closer to population centers.
I find the company&#8217;s industrial strategy particularly well-timed. FRP Holding aims to double its industrial segment over five years by delivering three new industrial assets every two years.
This aggressive expansion targets markets where demand for modern warehouse and distribution facilities continues growing while new supply remains constrained.
One of the most compelling aspects of FRP Holdings that involves its ownership structure and management alignment. The Baker family owns approximately 35% of the company, with the CEO owning 14.8% and other family members owning an additional 20.8%.
Company CEO John Baker is the largest shareholder with 15% of shares outstanding.
This represents serious skin in the game.
&nbsp;When management owns more than one-third of the business, their interests align perfectly with my interests as an outside shareholder.
The Baker family has shown that they are willing to sell if the right offer presents itself, which creates substantial shareholder value.
They have also demonstrated disciplined capital allocation, evidenced by the company repurchasing $20 million of shares during the pandemic below NAV.
I see FRP Holding's development pipeline providing multiple catalysts for future growth. In 2025, the company anticipates moving forward with two multifamily projects outside the DC area, one in South Carolina and the other in southwest Florida.
The company&#8217;s development expertise spans nearly four decades. Through its subsidiaries, FRP Development Corp &amp; Florida Rock Properties, Inc., FRP Holdings has nearly 40 years of development experience.
Several factors contribute to FRP Holding's relative obscurity among investors, which I view as an opportunity. FRP Holdings is covered by 4 analysts, with 0 of those analysts submitting estimates of revenue or earnings used as inputs to reports. The company operates in unfashionable sectors, mining royalties, apartment buildings, and warehouses, rather than the technology or growth companies that capture headlines.
FRPH does not currently pay a dividend, which eliminates income-focused investors from the shareholder base.
The company&#8217;s complex structure across multiple real estate segments requires more analysis than most investors want to undertake. This complexity creates the opportunity for those of us willing to do the work.
I believe FRP Holdings represents everything attractive about the commercial real estate opportunity I described. The company combines steady cash flows from mining royalties, growth potential from industrial development, and strategic positioning in recession-resistant Washington D.C. multifamily markets.
Management owns more than one-third of the business and has demonstrated disciplined capital allocation over decades.
This combination of quality assets, aligned management, and market neglect creates exactly the type of contrarian opportunity that I believe patient investors should embrace.
For investors willing to step into the liver and onions of today&#8217;s financial markets, I see FRP Holdings offering compelling exposure to the commercial real estate renaissance that nobody wants to discuss. The best investments you will ever make are those where almost nobody else agrees with you, and right here, almost nobody is paying attention to FRP Holdings.

Opinion

CBRE

FRPH

SBUX

Under the Radar: The Contrarian Case for Commercial Real Estate Is Getting Stronger

Amazon Pharmacy has announced two updates to make medication management easier and more accessible for millions of customers across the U.S., especially caregivers <a target="_blank" href="https://www.benzinga.com/general/health-care" rel="noreferrer noopener">and Medicare patients</a>.
The enhancements include a new caregiver feature and expanded access to its PillPack service for Medicare beneficiaries.
The caregiver support <a target="_blank" href="https://www.aboutamazon.com/news/retail/amazon-pharmacy-caregiver-medicare-pillpack" rel="noreferrer noopener">feature</a> allows Amazon Pharmacy customers to invite trusted individuals to manage medications on their behalf.
Once verified, caregivers can oversee prescriptions through their own Amazon accounts.
Also Read: <a target="_blank" href="https://www.benzinga.com/markets/large-cap/25/06/45748544/walmart-leverages-automation-and-ai-to-cut-costs-and-grow-paving-the-way-for-other-retailers-report" rel="noreferrer noopener">Walmart Leverages Automation And AI To Cut Costs And Grow, Paving The Way For Other Retailers: Report</a>
According to AARP, this update addresses a growing need: One in five U.S. adults, or about 53 million people, cares for an aging family member. Many spend the equivalent of a full workday each month coordinating health care, with medication management being among the most complex tasks.
Setting up caregiver access is simple: A customer logs into their Amazon Pharmacy account and sends an invitation via mobile phone number. After verifying a few details, like the customer&#8217;s date of birth, the caregiver receives a secure link by text message and can begin managing prescriptions from their account.
In addition, Amazon Pharmacy has expanded access to its PillPack service for Medicare Part D members.
PillPack offers personalized medication packets organized by date and time, designed to simplify the daily routine of people taking multiple prescriptions.
This service is now available to over 50 million Medicare Part D beneficiaries, helping eliminate the burden of sorting pills and tracking refill schedules. Eligible customers can sign up through their Amazon Pharmacy account to enroll.
Customers will receive monthly pre-sorted packet shipments after reviewing their medications and insurance details. Amazon coordinates all refills so medications arrive together each month.
Amazon Pharmacy offers one-time prescriptions and ongoing medication needs through the Amazon app.
The platform provides delivery updates via text or email and offers Prime members in select cities—including New York City, Los Angeles, and Seattle—free same-day delivery.
The pharmacy accepts most major insurance plans, including Medicare Part D nationwide and Medicaid in select states.
Prime members benefit from additional savings through RxPass and other Prime-exclusive discounts, with potential savings of up to 80% on thousands of medications when paying without insurance.
PillPack services are free and include 24/7 access to pharmacists and monthly medication deliveries.
Amazon bought PillPack seven years ago for over $750 million, but it still hasn&#8217;t revealed how much money its Amazon Pharmacy business is making in its quarterly earnings.
According to Forbes, <a href="https://www.forbes.com/sites/brucejapsen/2025/06/03/amazon-a-tiny-pharmacy-player-seeks-to-dent-cvs-and-walgreens-medicare-share/" target="_blank" rel="noreferrer noopener">studies</a> show that CVS Health (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/CVS#NYSE">CVS</a>) and Walgreens Boots Alliance (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/WBA#NASDAQ">WBA</a>) owned Walgreens control about 40% of the U.S. prescription drug market combined, while Amazon holds less than 1%. CVS and Walgreens do not share how many Medicare Part D prescriptions they fill.
Now, Amazon Pharmacy is adding features aimed at seniors to break into the fast-growing Medicare market, as more than 11,000 Americans turn 65 daily.
Most recently, Talkspace (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/TALK#NASDAQ">TALK</a>), an online behavioral health company, collaborated with Amazon Pharmacy to simplify the pharmacy experience for Talkspace members and streamline medication management and adherence support for providers.
Talkspace members can <a target="_blank" href="https://www.businesswire.com/news/home/20250529796020/en/Talkspace-Becomes-First-Behavioral-Health-Provider-to-Integrate-with-Amazon-Pharmacy-Offering-Psychiatry-Services-and-a-More-Seamless-Medication-Management-Experience" rel="noreferrer noopener">fulfill</a> prescriptions from their Talkspace provider through Amazon Pharmacy.
Price Action: AMZN stock is up 0.49% at $207.67 at the last check on Tuesday.
Read Next:
<ul class="wp-block-list">
<li><a href="https://www.benzinga.com/markets/large-cap/25/06/45745834/nio-stock-drops-after-q1-results-and-outlook-disappoints-the-street-margins-shrink" target="_blank" rel="noreferrer noopener">Nio Stock Drops After Q1 Results And Outlook Disappoints The Street, Margins Shrink</a></li>
</ul>
Photo by MACH Photos via Shutterstock

Large Cap

Health Care

General

AMZN

TALK

Amazon Pharmacy Challenges CVS Health And Walgreens Dominance, Unveils New Features To Expand Medicare Access

Walgreens Boots Alliance's (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/WBA#NYSE">WBA</a>) short percent of float has fallen 7.68% since its last report. The company recently reported that it has 33.89 million shares sold short, which is 4.69% of all regular shares that are available for trading. Based on its trading volume, it would take traders 1.95 days to cover their short positions on average.
<h3>Why Short Interest Matters</h3>
Short interest is the number of shares that have been sold short but have not yet been covered or closed out. <a href="https://www.benzinga.com/money/how-to-short-a-stock?adType=benzinga-insights&amp;ad=short-interest&amp;campaign=wallstreetadvantage">Short selling</a> is when a trader sells shares of a company they do not own, with the hope that the price will fall. Traders make money from short selling if the price of the stock falls and they lose if it rises.
Short interest is important to track because it can act as an indicator of market sentiment towards a particular stock. An increase in short interest can signal that investors have become more bearish, while a decrease in short interest can signal they have become more bullish.
See Also: <a href="https://www.benzinga.com/short-interest?adType=benzinga-insights&amp;ad=short-interest&amp;campaign=wallstreetadvantage">List of the most shorted stocks</a>
<h3>Walgreens Boots Alliance Short Interest Graph (3 Months)</h3>
<img src="https://www.benzinga.com/files/images/story/2025/1745856022_0.png" alt="short_fig" />
As you can see from the chart above the percentage of shares that are sold short for Walgreens Boots Alliance has declined since its last report. This does not mean that the stock is going to rise in the near-term but traders should be aware that less shares are being shorted.
<h3>Comparing Walgreens Boots Alliance's Short Interest Against Its Peers</h3>
Peer comparison is a popular technique amongst analysts and investors for gauging how well a company is performing. A company's peer is another company that has similar characteristics to it, such as industry, size, age, and financial structure. You can find a company's peer group by reading its 10-K, proxy filing, or by doing your own similarity analysis.
According to <a href="https://www.benzinga.com/pro/">Benzinga Pro</a>, Walgreens Boots Alliance's peer group average for short interest as a percentage of float is 4.43%, which means the company has more short interest than most of its peers.
Did you know that increasing short interest can actually be bullish for a stock? <a href="https://www.benzinga.com/money/how-to-make-money-on-a-short-squeeze?adType=benzinga-insights&amp;ad=short-interest&amp;campaign=wallstreetadvantage">This post by Benzinga Money explains how you can profit from it.</a>
This article was generated by Benzinga's automated content engine and was reviewed by an editor.

Short Sellers

Short Ideas

Trading Ideas

Peering Into Walgreens Boots Alliance's Recent Short Interest

Walgreens Has Teamed Up With Guild To Launch PharmStart, A First-of-its-kind, Fully Funded Online Education Program Designed To Help Eligible Team Members Meet The Prerequisite Requirements For Pharmacy School

Walgreens Boots Alliance Inc (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/WBA#NASDAQ">WBA</a>) on Monday said it will pay $300 million to resolve federal allegations that the company filled millions of invalid prescriptions for opioids <a href="https://www.benzinga.com/topic/opioids">and other controlled substances</a>.
Earlier this year, the U.S. Department of Justice filed a civil complaint against Walgreens and its subsidiaries, alleging widespread violations of the Controlled Substances Act (CSA) and <a href="https://www.benzinga.com/25/01/43104245/justice-department-accuses-walgreens-of-violating-drug-laws-in-opioid-epidemic-ignored-red-flags-in-opioid-crisis" target="_blank" rel="noreferrer noopener">False Claims Act (FCA)</a>.
The settlement, announced by the Justice Department, Drug Enforcement Administration (DEA), and the Department of Health and Human Services Office of Inspector General (HHS-OIG), addresses violations of the Controlled Substances Act and False Claims Act.
An additional $50 million will be <a target="_blank" href="https://www.justice.gov/opa/pr/walgreens-agrees-pay-350m-illegally-filling-unlawful-opioid-prescriptions-and-submitting" rel="noreferrer noopener">owed</a> if Walgreens is sold or merged before fiscal year 2032.
Sycamore Partners agreed to acquire Walgreens for $11.45 per <a href="https://www.benzinga.com/25/03/44377660/walgreens-executive-chair-stefano-pessina-seeks-to-strengthen-control-with-nearly-double-stake" target="_blank" rel="noreferrer noopener">share in March</a>.
Federal authorities alleged that from August 2012 to March 2023, Walgreens knowingly dispensed millions of controlled substance prescriptions that raised serious red flags.
These included excessive opioid quantities, early refills, and combinations known as the "trinity," a high-risk cocktail of drugs often linked to abuse. Despite clear signs these prescriptions lacked legitimate medical purposes, Walgreens pharmacists were allegedly pressured to prioritize speed over due diligence.
Also Read: <a target="_blank" href="https://www.benzinga.com/general/health-care/25/04/44685591/walgreens-boots-alliance-q2-earnings-beats-expectations-suspends-guidance-amid-pending-private-equity-deal-with-sycamore-partners" rel="noreferrer noopener">Walgreens Boots Alliance Q2 Profit Falls 47.5%, Suspends Guidance On Pending Private Equity Deal</a>
According to the complaint, Walgreens&#8217; internal practices further contributed to the misconduct. Compliance officials reportedly failed to act on substantial evidence of unlawful dispensing. The company allegedly withheld critical information from pharmacists, including internal prescriber data, and blocked efforts to warn colleagues about potentially problematic prescribers.
The Justice Department accused Walgreens of creating an environment that discouraged pharmacists from taking necessary steps to ensure valid prescriptions.
Alongside the financial settlement, Walgreens has agreed to implement long-term compliance measures. For example, it will require pharmacists to verify the legitimacy of controlled substance prescriptions. It will also conduct annual training, and ensure staffing levels support legal compliance.
Walgreens must also block prescriptions from prescribers known to issue illegitimate prescriptions.
Separately, Walgreens entered into a five-year Corporate Integrity Agreement with HHS-OIG, which establishes a comprehensive compliance program. The process includes employee training, oversight by the company's board, and regular reporting to HHS-OIG regarding controlled substances.
Following the settlement, the U.S. government moved to dismiss its complaint. Walgreens will seek to dismiss a related declaratory judgment case filed in Texas.
In November, Walgreens agreed to pay $100 million to settle a proposed class action lawsuit over its <a href="https://www.benzinga.com/news/large-cap/24/11/41741814/walgreens-agrees-to-100-million-settlement-over-alleged-deceptive-pricing-of-generic-drugs">Prescription Savings Club</a>.
Price Action: Walgreens stock is down 0.46% at $10.84 at the last check Monday.
Read Next:
<ul>
<li><a href="https://www.benzinga.com/25/04/44903741/fda-eases-monitoring-requirements-for-bristol-myers-heart-drug-camzyos-analyst-sees-as-timely-boost-ahead-of-rivals-review" target="_blank" rel="noreferrer noopener">Bristol Myers Analyst Says FDA Update Is A Win For Camzyos With Simpler Use, Broader Reach</a></li>
</ul>
Image: Shutterstock

Legal

Walgreens Must Pay $300 Million In Opioid Case, Additional $50 Million If Sold Or Merged Before 2032

<a href="https://www.justice.gov/opa/pr/walgreens-agrees-pay-350m-illegally-filling-unlawful-opioid-prescriptions-and-submitting" title="https://www.justice.gov/opa/pr/walgreens-agrees-pay-350m-illegally-filling-unlawful-opioid-prescriptions-and-submitting">https://www.justice.gov/opa/pr/walgreens-agrees-pay-350m-illegally-filling-unlawful-opioid-prescriptions-and-submitting</a>

Reported Earlier: 'Walgreens Agrees To Pay Up To $350M For Illegally Filling Unlawful Opioid Prescriptions And For Submitting False Claims To The Federal Government'

Walgreens Boots Alliance's (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/WBA#NYSE">WBA</a>) short percent of float has fallen 20.13% since its last report. The company recently reported that it has 36.69 million shares sold short, which is 5.08% of all regular shares that are available for trading. Based on its trading volume, it would take traders 2.63 days to cover their short positions on average.
<h3>Why Short Interest Matters</h3>
Short interest is the number of shares that have been sold short but have not yet been covered or closed out. <a href="https://www.benzinga.com/money/how-to-short-a-stock?adType=benzinga-insights&amp;ad=short-interest&amp;campaign=wallstreetadvantage">Short selling</a> is when a trader sells shares of a company they do not own, with the hope that the price will fall. Traders make money from short selling if the price of the stock falls and they lose if it rises.
Short interest is important to track because it can act as an indicator of market sentiment towards a particular stock. An increase in short interest can signal that investors have become more bearish, while a decrease in short interest can signal they have become more bullish.
See Also: <a href="https://www.benzinga.com/short-interest?adType=benzinga-insights&amp;ad=short-interest&amp;campaign=wallstreetadvantage">List of the most shorted stocks</a>
<h3>Walgreens Boots Alliance Short Interest Graph (3 Months)</h3>
<img src="https://www.benzinga.com/files/images/story/2025/1744380030_0.png" alt="short_fig" />
As you can see from the chart above the percentage of shares that are sold short for Walgreens Boots Alliance has declined since its last report. This does not mean that the stock is going to rise in the near-term but traders should be aware that less shares are being shorted.
<h3>Comparing Walgreens Boots Alliance's Short Interest Against Its Peers</h3>
Peer comparison is a popular technique amongst analysts and investors for gauging how well a company is performing. A company's peer is another company that has similar characteristics to it, such as industry, size, age, and financial structure. You can find a company's peer group by reading its 10-K, proxy filing, or by doing your own similarity analysis.
According to <a href="https://www.benzinga.com/pro/">Benzinga Pro</a>, Walgreens Boots Alliance's peer group average for short interest as a percentage of float is 5.19%, which means the company has less short interest than most of its peers.
Did you know that increasing short interest can actually be bullish for a stock? <a href="https://www.benzinga.com/money/how-to-make-money-on-a-short-squeeze?adType=benzinga-insights&amp;ad=short-interest&amp;campaign=wallstreetadvantage">This post by Benzinga Money explains how you can profit from it.</a>
This article was generated by Benzinga's automated content engine and was reviewed by an editor.

What Does the Market Think About Walgreens Boots Alliance?

U.S. stock futures were volatile on Wednesday after the equities reversed gains on Tuesday following President Donald Trump&#8216;s 104% tariff on China. Futures of major benchmark indices were mixed in premarket.
The White House Press Secretary Karoline Leavitt <a href="https://www.benzinga.com/economics/macro-economic-events/25/04/44698697/markets-reverse-gains-as-trumps-104-china-tariff-announcement-rattles-wall-street">confirmed that Trump&#8217;s retaliatory</a> 104% tariff on Chinese imports would take effect at 12:01 a.m. ET Wednesday. Her remarks triggered a sharp deterioration in market sentiment and reignited fears of a global trade escalation.
Despite growing geopolitical concerns surrounding China, a new U.S. Chamber of Commerce Foundation <a href="https://www.benzinga.com/news/global/25/04/44700937/us-companies-stick-with-china-as-trump-tariffs-take-effect-report">report highlighted by</a> The Wall Street Journal reveals that most surveyed companies still find significant strategic advantages in staying or growing their operations there.
This finding underscores a divergence between Washington&#8217;s &#8220;selective decoupling&#8221; efforts and the deep reliance of corporate America on China&#8217;s manufacturing, workforce, and consumer base.
Major indices were significantly down from recent highs as of Tuesday&#8217;s close. The S&amp;P 500 was 18.95% lower, the Nasdaq 100 was down 23.10%, and the Dow Jones declined 16.48%, following a week of tariff-driven selloffs.
The 10-year Treasury bond yielded 4.35% and the two-year bond was at 3.80%. However, the CME Group's FedWatch&nbsp;<a href="https://www.cmegroup.com/markets/interest-rates/cme-fedwatch-tool.html">tool</a>‘s projections showed markets pricing a 58.3% likelihood of the Federal Reserve keeping the current interest rates unchanged in its May meeting.
<figure class="wp-block-table is-style-stripes"> 
<table>
<tbody>
<tr>
<td>Futures</td>
<td>Change (+/-)</td>
</tr>
<tr>
<td>Dow Jones</td>
<td>-0.06%</td>
</tr>
<tr>
<td>S&amp;P 500</td>
<td>0.22%</td>
</tr>
<tr>
<td>Nasdaq 100</td>
<td>0.64%</td>
</tr>
<tr>
<td>Russell 2000</td>
<td>-0.17%</td>
</tr>
</tbody>
</table>
</figure>
The SPDR S&amp;P 500 ETF Trust (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/SPY#NYSE">SPY</a>) and Invesco QQQ Trust ETF (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/QQQ#NASDAQ">QQQ</a>), which track the S&amp;P 500 index and Nasdaq 100 index, respectively, were higher in premarket on Wednesday. The SPY was up 0.30% to $497.98, while the QQQ advanced 0.63% to $418.70, according to <a href="https://pro.benzinga.com/dashboard">Benzinga Pro</a> data.
Cues From Last Session:
Consumer discretionary, materials, and energy sectors led a broad decline in U.S. stocks on Tuesday, as the S&amp;P 500 closed entirely in negative territory.
The selloff intensified after the President&#8217;s 104% tariff.
Among individual tech giants, Apple Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/AAPL#NASDAQ">AAPL</a>), Tesla Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/TSLA#NASDAQ">TSLA</a>), and Amazon.com Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/AMZN#NASDAQ">AMZN</a>) saw significant drops, while Nvidia Corp. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/NVDA#NASDAQ">NVDA</a>) also traded lower.
In other news, Walgreens Boots Alliance Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/WBA#NASDAQ">WBA</a>) reported better-than-expected earnings, and small business optimism hit its lowest point since October 2024.
The Dow Jones index slumped 320 points or 0.84% to 37,645.59, whereas the S&amp;P 500 index fell 1.57% to 4,982.77. Nasdaq Composite declined to end 2.15% lower at 15,267.91, and the small-cap gauge, Russell 2000, tumbled 2.73% to 1,760.71.
<figure class="wp-block-table is-style-stripes"> 
<table>
<tbody>
<tr>
<td>Index</td>
<td>Performance (+/-)</td>
<td>Value</td>
</tr>
<tr>
<td>Nasdaq Composite</td>
<td>-2.15%</td>
<td>15,267.91</td>
</tr>
<tr>
<td>S&amp;P 500</td>
<td>-1.57%</td>
<td>4,982.77</td>
</tr>
<tr>
<td>Dow Jones</td>
<td>-0.84%</td>
<td>37,645.59</td>
</tr>
<tr>
<td>Russell 2000</td>
<td>-2.73%</td>
<td>1,760.71</td>
</tr>
</tbody>
</table>
</figure>
Insights From Analysts:
In this environment of heightened uncertainty, Julia Khandoshko, CEO at European broker Mind Money, advises investors to focus on capital preservation rather than chasing high returns.
&#8220;The most rational strategy in the short term is to focus on liquidity, reliable fixed-income instruments, and safe haven assets such as gold. This is not an attempt to make money but a need to preserve capital in conditions of high uncertainty,&#8221; she adds.
Even nations currently enjoying a trade surplus shouldn&#8217;t be complacent, warns Khandoshko. She points to the danger of stagflation – a damaging combination of stalled economic growth and ongoing inflation – using Japan&#8217;s long-lasting difficulties as a stark example.
The widening 3-year SOFR swap spread is signaling <a href="https://www.benzinga.com/government/regulations/25/04/44705659/cathie-wood-points-to-serious-liquidity-issues-as-overnight-borrowing-rate-spreads-widen-o">growing liquidity problems</a> within the U.S. banking system, according to Ark Invest CEO Cathie Wood. She argues that this crisis necessitates swift solutions, including a trade agreement and aggressive Federal Reserve intervention, emphasizing the urgency with &#8220;No more time to waste.&#8221;
This spread, a key indicator of U.S. banking liquidity, represents the difference between the fixed rate in a SOFR-based swap and the yield on a government bond of the same maturity.
SOFR, the Secured Overnight Financing Rate, is the benchmark reflecting the cost of overnight cash borrowing used across various financial transactions, and its widening spread adds to existing concerns about emerging liquidity issues in the U.S. market.
<figure class="wp-block-embed is-type-rich is-provider-twitter wp-block-embed-twitter"> 
<div class="wp-block-embed__wrapper">
<blockquote class="twitter-tweet" data-width="500" data-dnt="true">As Zerohedge notes, this swap spread is suggesting serious liquidity issues in the US banking system. This crisis is calling out for some kind of Mar-a-Lago Accord on free trade, in tandem with serious support from the Fed? No more time to waste. <a href="https://t.co/5VXYqLJemJ">https://t.co/5VXYqLJemJ</a>
&mdash; Cathie Wood (@CathieDWood) <a href="https://twitter.com/CathieDWood/status/1909816910033678801?ref_src=twsrc%5Etfw">April 9, 2025</a></blockquote>
<script async src="https://platform.twitter.com/widgets.js" charset="utf-8"></script></div>
</figure>
Meanwhile, Ed Yardeni of Yardeni Research suggests that "Fixed-income investors may be starting to worry that the Chinese and other foreigners might start selling their U.S. Treasuries," after Trump levied 104% tariff duties on China after the latter's retaliation.
Adding to the market unease, credit markets are exhibiting increasing strain, evidenced by a rapidly widening yield spread between high-yield corporate bonds and the 10-year Treasury.
Data from Yardeni indicates this spread reached 407 basis points as of April 7th, signaling declining investor confidence and growing concerns about an economic slowdown or potential recession.
"The good news is that the Fed Put will probably make a quick comeback if this happens," said Yardeni.
See Also: <a href="https://www.benzinga.com/money/how-to-trade-futures">How to Trade Futures</a> 
Upcoming Economic Data
Here&#8217;s what investors will keep an eye on Wednesday:
<ul>
<li>February&#8217;s wholesale inventories data will be released by 10:00 a.m., and Richmond Fed President Tom Barkin will speak at 11:00 a.m. ET.</li>
</ul>
<ul>
<li>Minutes of Fed&#8217;s March FOMC meeting will be out by 2:00 p.m. ET.</li>
</ul>
Stocks In Focus:
<ul>
<li>Delta Air Lines Inc. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/DAL#NYSE">DAL</a>) declined 1.11% in premarket on Tuesday before the opening bell. Analysts expect a quarterly earnings of 38 cents per share on revenue of $13.02 billion.</li>
<li>Simply Good Foods Co. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/SMPL#NASDAQ">SMPL</a>) was up 1.45% as Wall Street expects it to report earnings of 40 cents per share on revenue of $354.43 million before the opening bell.</li>
<li>Constellation Brands Inc. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/STZ#NYSE">STZ</a>) was down 1.10% ahead of its earnings call after the closing bell. Analysts expect a quarterly earnings of $2.28 per share on revenue of $2.13 billion.</li>
<li>Kura Sushi USA Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/KRUS#NASDAQ">KRUS</a>) dropped 3.28% after posting downbeat results for its second quarter. The company also said it sees FY25 total sales of $275 million to $279 million, versus market estimates of $280.741 million.</li>
<li>Aehr Test Systems (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/AEHR#NASDAQ">AEHR</a>) climbed 1.92% after posting better-than-expected earnings and sales results for its third quarter on Tuesday.</li>
<li>Redwire Corp. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/RDW#NYSE">RDW</a>) was 2.98% higher after it announced to jointly pursue commercial lunar missions with ispace U.S., including NASA CLPS, leveraging Redwire&#8217;s space infrastructure and ispace U.S.&#8217;s lunar transportation.</li>
<li>Marsh &amp; McLennan Companies Inc. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/MMC#NYSE">MMC</a>) jumped 17.83% as it announced the acquisition of Arthur Hall Insurance on April 2.</li>
<li>Vincerx Pharma Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/VINC#NASDAQ">VINC</a>) plunged 52.39% after disclosing that it has terminated the previously announced non-binding Letter of Intent with Global Digital Holdings regarding a potential merger.</li>
<li>Cartesian Therapeutics Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/RNAC#NASDAQ">RNAC</a>) tumbled 36.97% after reporting 12-month data for lead cell therapy in myasthenia gravis patients.</li>
</ul>
Commodities, Gold, And Global Equity Markets:
Crude oil futures were trading lower in the early New York session by 2.59% to hover around $57.82 per barrel.
Gold Spot US Dollar advanced 2.04% to hover around $3,043.09 per ounce. Its fresh record high stood at $3,168.04 per ounce. The U.S. Dollar Index spot was lower by 0.49% at the 102.450 level.
Asian markets were mostly lower on Wednesday. Except for China&#8217;s CSI 300 and Hong Kong's Hang Seng index, India's S&amp;P BSE Sensex, Japan's Nikkei 225, Australia's ASX 200, and South Korea's Kospi index declined. European markets were also lower in early trade.
Read Next:
<ul>
<li><a href="https://www.benzinga.com/government/regulations/25/04/44705659/cathie-wood-points-to-serious-liquidity-issues-as-overnight-borrowing-rate-spreads-widen-on-spiking-treasury-yields-this-crisis-is-calling-out-for-some-kind-of-mar-a-lago-accord">Cathie Wood Points To &#8216;Serious Liquidity Issues&#8217; As Overnight Borrowing Rate Spreads Widen On Spiking Treasury Yields</a></li>
</ul>
Photo courtesy: Shutterstock

Equities

Futures

Economics

Federal Reserve

Pre-Market Outlook

AAPL

AEHR

KRUS

NVDA

RNAC

SMPL

TSLA

VINC

US Stocks Futures Trade Mixed Ahead Of Opening Bell: 'Preserve Capital In Conditions Of High Uncertainty,' Says Expert

The CNN Money Fear and Greed index showed an increase in the overall fear level, while the index remained in the &#8220;Extreme Fear&#8221; zone on Tuesday.
U.S. stocks settled lower on Tuesday, with the Dow Jones index falling more than 300 points during the session after White House Press Secretary Karoline Leavitt confirmed that President Donald Trump&#8217;s retaliatory 104% tariff on Chinese imports would take effect at 12:01 a.m. ET Wednesday.
Among the Magnificent Seven, Apple Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/AAPL#NASDAQ">AAPL</a>) turned sharply lower, down 5%, while Tesla Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/TSLA#NASDAQ">TSLA</a>) shed 4.9% and Amazon.com Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/AMZN#NASDAQ">AMZN</a>) slipped 2.6%. Nvidia Corp. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/NVDA#NASDAQ">NVDA</a>) shares also dropped 1.4% during the session.
Walgreens Boots Alliance Inc (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/WBA#NASDAQ">WBA</a>) on Tuesday reported better-than-expected earnings for its second quarter.
On the economic data front, the NFIB Small Business Optimism Index declined 3.3 points to a reading of 97.4 in March, recording its weakest level since October 2024 and down from market estimates of 101.3.
All sectors on the S&amp;P 500 closed on a negative note, with consumer discretionary, materials, and energy stocks recording the biggest losses on Tuesday.
The Dow Jones closed lower by around 320 points to 37,645.59 on Tuesday. The S&amp;P 500 fell 1.57% to 4,982.77, while the Nasdaq Composite dipped 2.15% to 15,267.91 during Tuesday's session.
Investors are awaiting earnings results from Delta Air Lines, Inc. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/DAL#NYSE">DAL</a>), The Simply Good Foods Company (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/SMPL#NASDAQ">SMPL</a>), and Constellation Brands, Inc. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/STZ#NYSE">STZ</a>) today.
What is CNN Business Fear &amp; Greed Index?
At a current reading of 3.8, the index remained in the &#8220;Extreme Fear&#8221; zone on Tuesday, versus a prior reading of 4.5.
The Fear &amp; Greed Index is a measure of the current market sentiment. It is based on the premise that higher fear exerts pressure on stock prices, while higher greed has the opposite effect. The index is calculated based on seven equal-weighted indicators. The index ranges from 0 to 100, where 0 represents maximum fear and 100 signals maximum greediness.
Read Next: 
<ul>
<li><a href="https://www.benzinga.com/25/04/44684755/top-3-industrials-stocks-you-may-want-to-dump-this-month">Top 3 Industrials Stocks You May Want To Dump This Month</a> </li>
</ul>
Photo via Shutterstock

Earnings

Dow Dips Over 300 Points As US-China Trade Tensions Escalate: Apple, Tesla, Nvidia, Amazon Decline, Greed Index Remains In 'Extreme Fear' Zone

U.S. stocks traded higher midway through trading, with the Nasdaq Composite gaining more than 2% on Tuesday.
The Dow traded up 2.48% to 38,907.32 while the NASDAQ climbed 2.43% to 15,982.51. The S&amp;P 500 also rose, gaining, 2.38% to 5,182.79.
Check This Out: <a href="https://www.benzinga.com/25/04/44682228/wall-streets-most-accurate-analysts-spotlight-on-3-tech-stocks-delivering-high-dividend-yields">Wall Street&#8217;s Most Accurate Analysts Spotlight On 3 Tech Stocks Delivering High-Dividend Yields</a>
Leading and Lagging Sectors Information technology shares surged by 3.7% on Tuesday.
In trading on Tuesday, utilities shares rose by just by 1.1%.
Top Headline
Walgreens Boots Alliance Inc (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/WBA#NASDAQ">WBA</a>) on Tuesday reported better-than-expected earnings for its second quarter.
The company posted second-quarter sales of $38.59 billion, up 4.1% year over year (+4.7% on constant currency), beating the consensus of $38 billion, reflecting sales growth in the U.S. Retail Pharmacy and International segments. Adjusted EPS was 63 cents, down from $1.20 a year ago (47.5% decline), beating the consensus of 53 cents, according to data from Benzinga Pro.
Walgreens Boots Alliance withdrew its 2025 guidance under the M&amp;A deal with Sycamore Partners. The merger is expected to close in the fourth quarter of calendar year 2025.
Equities Trading UP &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
<ul>
<li>NextDecade Corporation (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/NEXT#NASDAQ">NEXT</a>) shares shot up 23% to $7.33 after the company announced a 20-year LNG sale and purchase agreement to supply 1.2 million tonnes per year to a subsidiary of Saudi Aramco.</li>
<li>Shares of 60 Degrees Pharmaceuticals, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/SXTP#NASDAQ">SXTP</a>)got a boost, surging 109% to $3.7395 after the company announced a patent license agreement with Yale&#8217;s School of Medicine and Public Health for the development and commercialization of Tafenoquine.</li>
<li>Cycurion, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/CYCU#NASDAQ">CYCU</a>) shares were also up, gaining 37% to $0.61 after the company announced an expanded partnership with Journal Technologies and a $22 million multi-year contract with a state police agency.</li>
</ul>
Equities Trading DOWN
<ul>
<li>Bluejay Diagnostics, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/BJDX#NASDAQ">BJDX</a>) shares dropped 57% to $3.2291 after the company announced entry into warrant inducement transaction for approximately $3.7 million in gross proceeds.</li>
<li>Shares of Tilray Brands, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/TLRY#NASDAQ">TLRY</a>) were down 8% to $0.5319. The company's third-quarter net revenue decreased from $188.3 million to $185.8 million, missing the consensus of $210.45 million.</li>
<li>CVRx, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/CVRX#NASDAQ">CVRX</a>) was down, falling 40% to $6.96 after Canaccord Genuity cut its price target on the stock from $23 to $18.</li>
</ul>
Commodities In commodity news, oil traded up 1.3% to $61.47 while gold traded up 1.8% at $3,026.10.
Silver traded up 2.7% to $30.415 on Tuesday, while copper rose 0.8% to $4.2205.
Euro zone
European shares were higher today. The eurozone's STOXX 600 gained 3.67%, Germany's DAX 40 gained 3.17% and France's CAC 40 climbed 3.54%. Spain's IBEX 35 Index rose 3.11%, while London's FTSE 100 gained 3.54%.
Asia Pacific Markets
Asian markets closed higher on Tuesday, with Japan's Nikkei 225 gaining 6.03%, China's Shanghai Composite gaining 1.58%, Hong Kong's Gang Seng index rising 1.51% and India's BSE Sensex gaining 1.49%.
Economics
The NFIB Small Business Optimism Index declined 3.3 points to a reading of 97.4 in March, recording its weakest level since October 2024 and down from market estimates of 101.3.
Now Read This: 
<ul>
<li><a href="https://www.benzinga.com/news/earnings/25/04/44682968/how-to-earn-500-a-month-from-delta-air-lines-stock-ahead-of-q1-earnings">How To Earn $500 A Month From Delta Air Lines Stock Ahead Of Q1 Earnings</a></li>
</ul>
Photo via Shutterstock

Eurozone

Commodities

Intraday Update

BJDX

CVRX

CYCU

SXTP

TLRY

Crude Oil Gains 1%; Walgreens Posts Upbeat Earnings

Walgreens Boots Alliance Inc&nbsp;(NASDAQ:&nbsp;WBA) on Tuesday reported second-quarter sales of $38.59 billion, up 4.1% year over year (+4.7% on constant currency), beating the&nbsp;<a target="_blank" href="https://www.benzinga.com/calendars/earnings" rel="noreferrer noopener">consensus of $38 billion</a>, reflecting sales growth in the&nbsp;U.S.&nbsp;Retail Pharmacy&nbsp;and International segments.
Adjusted operating income&nbsp;was&nbsp;$785 million&nbsp;compared to $900 million a year ago, reflecting lower&nbsp;U.S.&nbsp;retail sales in the current quarter and sale-leaseback gains in the year-ago quarter, partly offset by cost savings within&nbsp;U.S. Retail Pharmacy&nbsp;and <a target="_blank" href="https://www.benzinga.com/pressreleases/25/04/b44681111/walgreens-boots-alliance-reports-fiscal-2025-second-quarter-results" rel="noreferrer noopener">growth in&nbsp;U.S. Healthcare</a>.
Adjusted EPS was&nbsp;63 cents, down from $1.20 a year ago (47.5% decline), beating the consensus of 53 cents, according to data from&nbsp;<a target="_blank" href="https://benzinga.grsm.io/register174?tblci=GiCUX7wvU_AgmIIiQduNYr6JQuJQLy6SZJGvpyeZuCzyqiCN1VcoxvTN4f7-y-PqATDviEo" rel="noreferrer noopener">Benzinga Pro</a>.
Also Read: <a target="_blank" href="https://www.benzinga.com/25/03/44377660/walgreens-executive-chair-stefano-pessina-seeks-to-strengthen-control-with-nearly-double-stake" rel="noreferrer noopener">Walgreens&#8217; Executive Chair Stefano Pessina Seeks To Strengthen Control With Nearly Double Stake</a>
The U.S. Retail Pharmacy segment sales reached $30.4 billion, up 5.3%. Comparable sales increased 8.2%.
Pharmacy sales increased by 8.9%, and comparable pharmacy sales increased by 12.2%, each benefiting from higher branded drug inflation and prescription volume.
Comparable prescriptions increased by 3.4%, and prescriptions excluding immunizations increased by 3.9% compared to a year ago.
Total prescriptions filled in the quarter, including immunizations, increased 1.3% to 309 million.
Retail sales decreased by 5.5%, and comparable retail sales decreased by 2.8% compared with the year-ago quarter,&nbsp;driven by lower sales in discretionary categories, including beauty, seasonal, and general merchandise.
Cough cold flu season negatively impacted retail sales by approximately 45 basis points compared to the year-ago quarter, an improvement compared to the fiscal first quarter.
The U.S. Healthcare&nbsp;segment&#8217;s sales were&nbsp;$2.2 billion. VillageMD sales decreased 6.2%, CareCentrix sales increased 6.5%, and Shields sales rose 29.7%.
Guidance:&nbsp;Walgreens Boots Alliance withdrew its 2025 guidance under the M&amp;A deal with Sycamore Partners. The merger is expected to close in the <a target="_blank" href="https://www.benzinga.com/trading-ideas/movers/25/03/44182479/walgreens-stock-rises-as-company-inks-10b-deal-to-go-private" rel="noreferrer noopener">fourth quarter of calendar year 2025</a>.
In the first quarter of 2025, Walgreens Boots Alliance maintained fiscal 2025 adjusted EPS&nbsp;guidance of $1.40 – $1.80 versus the <a target="_blank" href="https://www.benzinga.com/general/health-care/25/01/42912519/walgreens-boots-alliance-stock-jumps-on-better-than-expected-q1-earnings-sticks-to-annual-profit-forecast" rel="noreferrer noopener">consensus of $1.52</a>.
The company&nbsp;<a target="_blank" href="https://investor.walgreensbootsalliance.com/static-files/b93516a3-ac11-4bf3-af48-08739983eaaf?tblci=GiCUX7wvU_AgmIIiQduNYr6JQuJQLy6SZJGvpyeZuCzyqiCN1VcoxvTN4f7-y-PqATDviEo" rel="noreferrer noopener">expected</a> growth in U.S. Healthcare and International offset by pressure in U.S. Retail Pharmacy, largely driven by weaker retail front end performance.
Price Action:&nbsp;WBA stock is up 1.63% at $10.88 at the last check Tuesday.
Read Next:
<ul>
<li><a href="https://www.benzinga.com/general/biotech/25/04/44671679/nih-faces-legal-battle-over-scientific-grant-cuts-and-political-influence" target="_blank" rel="noreferrer noopener">NIH Faces Legal Battle Over Scientific Grant Cuts And Political Influence</a></li>
</ul>
Image via Shutterstock

Guidance

Movers

Walgreens Boots Alliance Q2 Profit Falls 47.5%, Suspends Guidance On Pending Private Equity Deal

Given The Pending Transaction Pursuant To Which Walgreens Boots Alliance Will Be Acquired By Sycamore Partners, The Company Is Withdrawing Fiscal 2025 Guidance

Walgreens Boots Alliance (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/WBA#NASDAQ">WBA</a>) reported quarterly earnings of $0.63 per share which beat the analyst consensus estimate of $0.53 by 18.87 percent. This is a 47.5 percent decrease over earnings of $1.20 per share from the same period last year. The company reported quarterly sales of $38.59 billion which beat the analyst consensus estimate of $38.00 billion by 1.55 percent. This is a 4.15 percent increase over sales of $37.05 billion the same period last year.

Walgreens Boots Alliance Q2 2025 Adj EPS $0.63 Beats $0.53 Estimate, Sales $38.59B Beat $38.00B Estimate

U.S. stock futures rose on Tuesday following a volatile day of trading on Monday that led the indices to close on a mixed note. Futures of major benchmark indices were higher in premarket.
The sell-off that began on Thursday has driven the Nasdaq into bear market territory, whereas the S&amp;P 500 and Dow Jones continue to be in the correction zone.
As China&#8217;s Commerce Ministry said that it "<a href="https://www.benzinga.com/markets/25/04/44677506/china-resolutely-opposes-trumps-50-tariff-threat-vows-countermeasures-as-trade-tensions-jolt-markets?_gl=1kzrvdi_gcl_auNzQyMjgxNjUuMTczNzYwNzI4NQ.._gaZGVsZXRlZA.._ga_V7ZK73W7N0&#x2A;MTc0NDEwMDY0OS4yNDkuMC4xNzQ0MTAwNjQ5LjAuMC4w">resolutely opposes</a>" U.S. President Donald Trump‘s threat to impose additional 50% duties on Chinese imports, the ministry vowed to take countermeasures to protect its interests, intensifying trade tensions that have already triggered market turmoil.
Major indices were significantly down from recent highs as of Tuesday. The S&amp;P 500 was 17.65% lower, the Nasdaq 100 was down 21.56%, and the Dow Jones declined 15.77%, following a week of tariff-driven selloffs.
The 10-year Treasury bond yielded 4.17% and the two-year bond was at 3.77%. However, the CME Group's FedWatch <a href="https://www.cmegroup.com/markets/interest-rates/cme-fedwatch-tool.html">tool</a>&#8216;s projections showed markets pricing a 71.4% likelihood of the Federal Reserve keeping the current interest rates unchanged in its May meeting. 
<figure class="wp-block-table is-style-stripes"> 
<table>
<tbody>
<tr>
<td>Futures</td>
<td>Change (+/-)</td>
</tr>
<tr>
<td>Dow Jones</td>
<td>2.03%</td>
</tr>
<tr>
<td>S&amp;P 500</td>
<td>1.67%</td>
</tr>
<tr>
<td>Nasdaq 100</td>
<td>1.42%</td>
</tr>
<tr>
<td>Russell 2000</td>
<td>2.06%</td>
</tr>
</tbody>
</table>
</figure>
The SPDR S&amp;P 500 ETF Trust (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/SPY#NYSE">SPY</a>) and Invesco QQQ Trust ETF (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/QQQ#NASDAQ">QQQ</a>), which track the S&amp;P 500 index and Nasdaq 100 index, respectively, advanced in premarket on Tuesday. The SPY was up 1.13% to $510.07, while the QQQ declined 1.09% to $428.30, according to <a href="https://pro.benzinga.com/dashboard">Benzinga Pro</a> data.
Cues From Last Session:
Real estate, materials, and utilities sectors led Monday&#8217;s S&amp;P 500 decline, pulling the U.S. stocks to a mixed close, with the Dow Jones falling for its third consecutive session.
Conversely, communication services and information technology stocks bucked the trend, closing higher.
Within tech, Tesla Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/TSLA#NASDAQ">TSLA</a>) shares fell roughly 2.6%, while Apple Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/AAPL#NASDAQ">AAPL</a>) lost 3.7%. Market volatility stemmed from Trump&#8217;s Truth Social post, threatening 50% U.S. tariffs on China following China&#8217;s 34% retaliatory tariffs.
The Manheim Used Vehicle Value Index reported a 0.7% month-over-month drop in March, consistent with February&#8217;s decline.
The Dow Jones index slumped 349 points or 0.91% to 37,965.60, whereas the S&amp;P 500 index fell 0.23% to 5,062.25. Nasdaq Composite bucked the trend to end 0.099% higher at 15,603.26, and the small-cap gauge, Russell 2000, tumbled 0.92% to 1,810.14.
<figure class="wp-block-table is-style-stripes"> 
<table>
<tbody>
<tr>
<td>Index</td>
<td>Performance (+/-)</td>
<td>Value</td>
</tr>
<tr>
<td>Nasdaq Composite</td>
<td> 0.099%</td>
<td>15,603.26</td>
</tr>
<tr>
<td>S&amp;P 500</td>
<td>-0.23%</td>
<td>5,062.25</td>
</tr>
<tr>
<td>Dow Jones</td>
<td>-0.91%</td>
<td>37,965.60</td>
</tr>
<tr>
<td>Russell 2000</td>
<td>-0.92%</td>
<td>1,810.14</td>
</tr>
</tbody>
</table>
</figure>
Insights From Analysts:
Lawrence McDonald, founder of Bear Traps Report, calculates that<a href="https://www.benzinga.com/markets/bonds/25/04/44679299/trump-tariffs-triggers-historic-equity-wipeout-outpacing-covid-lehman-crashes-with-no-bond-rally-to-cushion-the-blow-says-lawrence-mcdonald"> Trump&#8217;s tariff-driven selloff</a> has obliterated $9 trillion in just six weeks, matching the COVID crash&#8217;s one-month losses and exceeding the 2008 Lehman collapse&#8217;s 12-month decline.
Only the 2022 inflation downturn saw greater losses, at $10 trillion over 11 months. Notably, unlike previous crises where bond yields plummeted, current 30-year yields remain high, near 4.5%, eliminating a traditional bond-market safety net. Reuters reports the global impact of these tariffs at a $10 trillion market wipeout.
<figure class="wp-block-embed is-type-rich is-provider-twitter wp-block-embed-twitter"> 
<div class="wp-block-embed__wrapper">
<blockquote class="twitter-tweet" data-width="500" data-dnt="true">What do Bonds Know? &#x2A;Last 20 years, large equity market risk-off events have &#8212; always &#8212; brought in &quot;flight to quality&quot; buyers of long duration U.S. Treasuries. Not this time. &#x2A;&#x2A;Book Ideas &#8211; &quot;How to Listen When Markets Speak&quot; on Amazon. <a href="https://t.co/naR2vpsuLr">pic.twitter.com/naR2vpsuLr</a>
&mdash; Lawrence McDonald (@Convertbond) <a href="https://twitter.com/Convertbond/status/1909236400127455548?ref_src=twsrc%5Etfw">April 7, 2025</a></blockquote>
<script async src="https://platform.twitter.com/widgets.js" charset="utf-8"></script></div>
</figure>
The VIX sustained levels above 45 for two consecutive days, closing at 45.31 on Monday and 46.98 on Tuesday. As former Luby Asset Management CIO Bill Luby noted, this marks the first such occurrence since the 2008-09 Great Financial Crisis and the 2020 COVID-19 pandemic.
<figure class="wp-block-embed is-type-rich is-provider-twitter wp-block-embed-twitter"> 
<div class="wp-block-embed__wrapper">
<blockquote class="twitter-tweet" data-width="500" data-dnt="true">Consecutive 45+ <a href="https://twitter.com/search?q=%24VIX&amp;src=ctag&amp;ref_src=twsrc%5Etfw">$VIX</a> closes are extremely rare. So rare that only two previous crises have included at least two 45+ closes in a row: the Great Financial Crisis of 2008-09 and the Pandemic of 2020.
&mdash; Bill Luby (@VIXandMore) <a href="https://twitter.com/VIXandMore/status/1909346105835634993?ref_src=twsrc%5Etfw">April 7, 2025</a></blockquote>
<script async src="https://platform.twitter.com/widgets.js" charset="utf-8"></script></div>
</figure>
A dramatic 118% surge in the VIX over three days marks its fifth-largest such spike. Creative Planning&#8217;s Charlie Bilello&#8216;s data shows that the two larger three-day VIX spikes of 176% in 2018 and 167% in 2015, preceded strong S&amp;P 500 returns over the following one to five years, leading Bilello to conclude that &#8220;high volatility/fear = opportunity&#8221;.
<figure class="wp-block-embed is-type-rich is-provider-twitter wp-block-embed-twitter"> 
<div class="wp-block-embed__wrapper">
<blockquote class="twitter-tweet" data-width="500" data-dnt="true">The <a href="https://twitter.com/search?q=%24VIX&amp;src=ctag&amp;ref_src=twsrc%5Etfw">$VIX</a> increased 118% over the last 3 trading days, the 5th biggest 3-day spike ever. What has happened in the past following the biggest <a href="https://twitter.com/search?q=%24VIX&amp;src=ctag&amp;ref_src=twsrc%5Etfw">$VIX</a> spikes? Stocks have tended to bounce back with above-average returns over the next 1-5 years. High volatility/fear = opportunity. <a href="https://t.co/3X373zS1K8">pic.twitter.com/3X373zS1K8</a>
&mdash; Charlie Bilello (@charliebilello) <a href="https://twitter.com/charliebilello/status/1909370006569206218?ref_src=twsrc%5Etfw">April 7, 2025</a></blockquote>
<script async src="https://platform.twitter.com/widgets.js" charset="utf-8"></script></div>
</figure>
Meanwhile, Bravos Research indicates a &#8220;risk-off&#8221; sentiment in the U.S. stock market, triggered by a gold-to-silver ratio breakout, currently at 99.59. This closely watched metric suggests investors are shifting from volatile silver to safe-haven gold, a pattern seen before the 2022, 2020, and 2008 market downturns.
<figure class="wp-block-embed is-type-rich is-provider-twitter wp-block-embed-twitter"> 
<div class="wp-block-embed__wrapper">
<blockquote class="twitter-tweet" data-width="500" data-dnt="true">15/ This is what the gold-to-silver ratio looks like since 2020 It just broke out above a major basing pattern that had been forming since 2022 This is a risk-off signal, showing traders are moving away from the more volatile silver and into gold <a href="https://t.co/YlcE5Q0oVm">pic.twitter.com/YlcE5Q0oVm</a>
&mdash; Bravos Research (@bravosresearch) <a href="https://twitter.com/bravosresearch/status/1909253763153436992?ref_src=twsrc%5Etfw">April 7, 2025</a></blockquote>
<script async src="https://platform.twitter.com/widgets.js" charset="utf-8"></script></div>
</figure>
See Also: <a href="https://www.benzinga.com/money/how-to-trade-futures">How to Trade Futures </a>
Upcoming Economic Data
Here&#8217;s what investors will keep an eye on Tuesday:
<ul>
<li>The NFIB optimism index for March will be out by 6:00 a.m., and San Francisco Fed President Mary Daly will speak at 8:00 a.m. ET.</li>
</ul>
Stocks In Focus:
<ul>
<li>Walgreens Boots Alliance Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/WBA#NASDAQ">WBA</a>) was up 1.31% in premarket on Tuesday before the opening bell. Analysts expect a quarterly earnings of 53 cents per share on revenue of $38 billion.</li>
</ul>
<ul>
<li>RPM International Inc. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/RPM#NYSE">RPM</a>) was down 0.19% as Wall Street expects it to report earnings of 49 cents per share on revenue of $1.51 billion before the opening bell.</li>
</ul>
<ul>
<li>Cal-Maine Foods Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/CALM#NASDAQ">CALM</a>) rose 0.59% ahead of its earnings call after the closing bell. Analysts expect a quarterly earnings of $10.90 per share on revenue of $1.43 billion.</li>
</ul>
<ul>
<li>Greenbrier Companies Inc. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/GBX#NYSE">GBX</a>) dropped 4.72% after posting downbeat results for its second quarter. The company reported quarterly sales of $762.1 million, which missed the analyst consensus estimate of $898.530 million.</li>
</ul>
<ul>
<li>Levi Strauss &amp; Co. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/LEVI#NYSE">LEVI</a>) surged 10.37% after reporting better-than-expected earnings for its first quarter on Monday. Levi also said its 2025 guidance remains unchanged, other than to reflect its Dockers business as a discontinued operation, and does not reflect any impact from the recently announced tariffs.</li>
</ul>
<ul>
<li>Marvell Technology Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/MRVL#NASDAQ">MRVL</a>) advanced 3.14% after it announced the sale of its automotive Ethernet business to Infineon for $2.5 billion in cash.</li>
</ul>
<ul>
<li>Viasat Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/VSAT#NASDAQ">VSAT</a>) was 1.32% higher after announcing the launch of Amara, its next-generation In-flight Connectivity (IFC) solution for commercial aviation.</li>
</ul>
<ul>
<li>P10 Inc. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/PX#NYSE">PX</a>) moved 0.70% higher after acquiring Madrid-based Qualitas Equity Funds for $63 million. Qualitas manages roughly $1 billion in fee-paying assets for over 1,300 partners.</li>
</ul>
<ul>
<li>Heavyweights, Nvidia Corporation (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/NVDA#NASDAQ">NVDA</a>) rose 2.41%, Apple Inc. advanced 1.34%, Microsoft Corp. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/MSFT#NASDAQ">MSFT</a>) gained 0.79%, Amazon.com Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/AMZN#NASDAQ">AMZN</a>) was 2.04% higher, and Tesla Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/TSLA#NASDAQ">TSLA</a>) climbed 1.89%.</li>
</ul>
Commodities, Gold, And Global Equity Markets:
Crude oil futures were trading higher in the early New York session by 0.05% to hover around $60.73 per barrel.
Gold Spot US Dollar advanced 0.82% to hover around $3,007.02 per ounce. Its fresh record high stood at $3,168.04 per ounce. The U.S. Dollar Index spot was lower by 0.14% at the 103.111 level.
Asian markets rose on Tuesday. India's S&amp;P BSE Sensex, Japan's Nikkei 225, Australia's ASX 200, China&#8217;s CSI 300, Hong Kong's Hang Seng, and South Korea's Kospi index advanced. European markets were also higher in early trade.
Read Next:
<ul>
<li><a href="https://www.benzinga.com/25/04/44679385/market-enters-risk-off-mode-as-analyst-predicts-this-signal-flashing-warnings-similar-to-2020-and-2008-crisis">Market Enters &#8216;Risk-Off&#8217; Mode As Analyst Predicts This Signal Flashing Warnings Similar To 2020, 2008 Crisis</a></li>
</ul>
Image via Shutterstock

Analyst Color

Market Summary

Treasuries

Analyst Ratings

CALM

LEVI

MRVL

MSFT

VSAT

Wall Street Eyes Recovery As S&P 500, Nasdaq Futures Rise After Trump's Tariff-Driven Selloff Wipes Out $9 Trillion In Six Weeks

<h3>Companies Reporting Before The Bell</h3>
• Tilray Brands (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/TLRY#NASDAQ">TLRY</a>) is expected to report quarterly loss at $0.03 per share on revenue of $209.77 million. 
• WD-40 (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/WDFC#NASDAQ">WDFC</a>) is estimated to report quarterly earnings at $1.42 per share on revenue of $154.40 million. 
• Walgreens Boots Alliance (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/WBA#NASDAQ">WBA</a>) is likely to report quarterly earnings at $0.53 per share on revenue of $37.99 billion. 
• RPM Intl (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/RPM#NYSE">RPM</a>) is likely to report quarterly earnings at $0.49 per share on revenue of $1.50 billion. 
<h3>Companies Reporting After The Bell</h3>
• Gold Resource (AMEX:<a class="ticker" href="https://www.benzinga.com/stock/GORO#AMEX">GORO</a>) is likely to report earnings for its fourth quarter. 
• Kura Sushi USA (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/KRUS#NASDAQ">KRUS</a>) is expected to report quarterly loss at $0.14 per share on revenue of $64.87 million. 
• Cal-Maine Foods (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/CALM#NASDAQ">CALM</a>) is expected to report quarterly earnings at $10.90 per share on revenue of $1.43 billion. 
• Techprecision (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/TPCS#NASDAQ">TPCS</a>) is estimated to report earnings for its third quarter. 
• Aehr Test System (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/AEHR#NASDAQ">AEHR</a>) is likely to report quarterly earnings at $0.04 per share on revenue of $17.76 million. 
• Mama's Creations (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/MAMA#NASDAQ">MAMA</a>) is likely to report quarterly earnings at $0.03 per share on revenue of $31.02 million. 
This article was generated by Benzinga's automated content engine and reviewed by an editor.

GORO

MAMA

TPCS

WDFC

Earnings Scheduled For April 8, 2025

The CNN Money Fear and Greed index showed some easing in the overall fear level, while the index remained in the &#8220;Extreme Fear&#8221; zone on Monday.
U.S. stocks settled mixed on Monday, with the Dow Jones index falling for the third straight session.
Tesla Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/TSLA#NASDAQ">TSLA</a>) shares fell around 2.6% on Monday, while Apple Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/AAPL#NASDAQ">AAPL</a>) lost 3.7% during the session.
On Truth Social, Trump stated that China had imposed retaliatory tariffs of 34%, on top of what he described as already record-setting tariffs, despite prior warnings that such measures would be met with significantly higher U.S. tariffs. He added that if China did not reverse the 34% hike by April 8, the United States would respond with additional tariffs of 50%, effective the following day.
On the economic data front, the Manheim Used Vehicle Value Index fell 0.7% month-over-month in March, matching the pace of decline in the previous month.
Most sectors on the S&amp;P 500 closed on a negative note, with real estate, materials, and utilities stocks recording the biggest losses on Monday. However, communication services and information technology stocks bucked the overall market trend, closing the session higher.
The Dow Jones closed lower by around 349 points to 37,965.60 on Monday. The S&amp;P 500 fell 0.23% to 5,062.25, while the Nasdaq Composite gained 0.10% at 15,603.26 during Monday's session.
Investors are awaiting earnings results from Walgreens Boots Alliance Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/WBA#NASDAQ">WBA</a>), RPM International Inc. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/RPM#NYSE">RPM</a>), and Cal-Maine Foods Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/CALM#NASDAQ">CALM</a>) today.
What is CNN Business Fear &amp; Greed Index?
At a current reading of 4.4, the index remained in the &#8220;Extreme Fear&#8221; zone on Monday, versus a prior reading of 4.0.
The Fear &amp; Greed Index is a measure of the current market sentiment. It is based on the premise that higher fear exerts pressure on stock prices, while higher greed has the opposite effect. The index is calculated based on seven equal-weighted indicators. The index ranges from 0 to 100, where 0 represents maximum fear and 100 signals maximum greediness.
Read Next: 
<ul>
<li><a href="https://www.benzinga.com/trading-ideas/short-ideas/25/04/44669062/top-3-health-care-stocks-that-may-crash-in-q2">Top 3 Health Care Stocks That May Crash In Q2</a> </li>
</ul>
Photo via Shutterstock

Dow Falls For 3rd Session Amid Trump's Tariff Threats As Apple, Tesla Decline: Greed Index Remains In 'Extreme Fear' Zone

Walgreens Boots Alliance, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/WBA#NASDAQ">WBA</a>) will release earnings results for the second quarter, before the <a href="https://www.benzinga.com/quote/WBA/earnings">opening bell on Tuesday, April 8.</a>
Analysts expect the company to report quarterly earnings at 53 cents per share, down from $1.2 per share in the year-ago period. According to data from <a href="https://pro.benzinga.com/dashboard">Benzinga Pro</a>, Walgreens projects quarterly revenue at $38.0 billion, compared to $37.05 billion a year earlier.
On March 6, Walgreens Boots Alliance entered an agreement to be acquired by private equity firm Sycamore Partners.
Walgreens shares gained 0.3% to close at $10.71 on Monday.
Benzinga readers can access the latest analyst ratings on the <a href="https://www.benzinga.com/analyst-ratings/analyst-color/22/09/28888638/exclusive-study-finds-benzinga-analyst-ratings-data-yields-market-beating-strategie">Analyst Stock Ratings</a> page. Readers can sort by stock ticker, company name, analyst firm, rating change or other variables.
Let's have a look at how Benzinga's most-accurate <a href="https://www.benzinga.com/quote/WBA/analyst-ratings">analysts have rated the company</a> in the recent period.
<ul>
<li>Deutsche Bank analyst George Hill downgraded the stock from Hold to Sell and cut the price target from $11 to $9 on Feb. 28, 2025. This analyst has an accuracy rate of 63%.</li>
<li>Truist Securities analyst David Macdonald maintained a Hold rating and lowered the price target from $13 to $12 on Jan. 31, 2025. This analyst has an accuracy rate of 69%.</li>
<li>RBC Capital analyst Ben Hendrix maintained a Sector Perform rating and raised the price target from $9 to $12 on Jan. 15, 2025. This analyst has an accuracy rate of 61%.</li>
<li>B of A Securities analyst Allen Lutz maintained an Underperform rating and boosted the price target from $7.5 to $8.5 on Jan. 13, 2025. This analyst has an accuracy rate of 61%.</li>
<li>UBS analyst Kevin Caliendo maintained a Neutral rating and increased the price target from $9 to $10 on Oct. 17, 2024. This analyst has an accuracy rate of 72%.</li>
</ul>
Considering buying WBA stock? Here&#8217;s what analysts think:
Read This Next: 
<ul>
<li><a href="https://www.benzinga.com/trading-ideas/short-ideas/25/04/44669062/top-3-health-care-stocks-that-may-crash-in-q2">Top 3 Health Care Stocks That May Crash In Q2</a> </li>
</ul>
Photo via Shutterstock

Price Target

Top Wall Street Forecasters Revamp Walgreens Price Expectations Ahead Of Q2 Earnings

With U.S. stock futures trading higher this morning on Tuesday, some of the stocks that may grab investor focus today are as follows:
<ul>
<li>Wall Street expects Walgreens Boots Alliance Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/WBA#NASDAQ">WBA</a>) to report quarterly earnings at 53 cents per share on revenue of $38 billion before the opening bell, according to data from <a href="https://pro.benzinga.com/dashboard">Benzinga Pro</a>. Walgreens shares fell 0.1% to $10.70 in after-hours trading.</li>
<li>The Greenbrier Companies Inc. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/GBX#NYSE">GBX</a>) posted downbeat results for its second quarter. The company reported quarterly sales of $762.1 million, which missed the analyst consensus estimate of $898.530 million. Greenbrier shares fell 2.9% to $43.43 in the after-hours trading session.</li>
<li>Analysts are expecting RPM International Inc. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/RPM#NYSE">RPM</a>) to post quarterly earnings at 49 cents per share on revenue of $1.51 billion. The company will release earnings before the markets open. RPM shares gained 2.6% to $109.48 in after-hours trading.</li>
</ul>
Check out our <a href="https://www.benzinga.com/premarket/">premarket coverage here</a>
<ul>
<li>Levi Strauss &amp; Co. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/LEVI#NYSE">LEVI</a>) reported better-than-expected earnings for its first quarter on Monday. Levi also said its 2025 guidance remains unchanged, other than to reflect its Dockers business as a discontinued operation, and does not reflect any impact from the recently announced tariffs. Levi Strauss shares jumped 7.4% to $14.50 in the after-hours trading session.</li>
<li>Analysts expect Cal-Maine Foods Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/CALM#NASDAQ">CALM</a>) to post quarterly earnings at $10.90 per share on revenue of $1.43 billion after the closing bell. Cal-Maine shares gained 2.2% to $95.49 in the after-hours trading session.</li>
</ul>
Check This Out: 
<ul>
<li><a href="https://www.benzinga.com/trading-ideas/short-ideas/25/04/44669062/top-3-health-care-stocks-that-may-crash-in-q2">Top 3 Health Care Stocks That May Crash In Q2</a> </li>
</ul>
Photo via Shutterstock

Walgreens, RPM International And 3 Stocks To Watch Heading Into Tuesday

Walgreens Boots Alliance (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/WBA#NASDAQ">WBA</a>) is gearing up to announce its quarterly earnings on Tuesday, 2025-04-08. Here's a quick overview of what investors should know before the release.
Analysts are estimating that Walgreens Boots Alliance will report an earnings per share (EPS) of $0.54.
The announcement from Walgreens Boots Alliance is eagerly anticipated, with investors seeking news of surpassing estimates and favorable guidance for the next quarter.
It's worth noting for new investors that guidance can be a key determinant of stock price movements.
<h3>Earnings Track Record</h3>
The company's EPS beat by $0.14 in the last quarter, leading to a 0.0% drop in the share price on the following day.
Here's a look at Walgreens Boots Alliance's past performance and the resulting price change:

<table>
<thead>
<tr>
<th>Quarter</th>
<th>Q1 2025</th>
<th>Q4 2024</th>
<th>Q3 2024</th>
<th>Q2 2024</th>
</tr>
</thead>
<tbody>
<tr>
<td>EPS Estimate</td>
<td>0.37</td>
<td>0.36</td>
<td>0.71</td>
<td>0.82</td>
</tr>
<tr>
<td>EPS Actual</td>
<td>0.51</td>
<td>0.39</td>
<td>0.63</td>
<td>1.20</td>
</tr>
<tr>
<td>Price Change %</td>
<td>28.000000000000004%</td>
<td>6.0%</td>
<td>-1.0%</td>
<td>3.0%</td>
</tr>
</tbody>
</table>

<img src="https://www.benzinga.com/files/images/story/2025/1744034412_0.png" alt="eps graph" />
<h3>Stock Performance</h3>
Shares of Walgreens Boots Alliance were trading at $10.68 as of April 04. Over the last 52-week period, shares are down 47.18%. Given that these returns are generally negative, long-term shareholders are likely a little upset going into this earnings release. 
<h3>Analyst Insights on Walgreens Boots Alliance</h3>
Understanding market sentiments and expectations within the industry is crucial for investors. This analysis delves into the latest insights on Walgreens Boots Alliance.
With 6 analyst ratings, Walgreens Boots Alliance has a consensus rating of Neutral. The average one-year price target is $11.08, indicating a potential 3.75% upside.
<h3>Comparing Ratings Among Industry Peers</h3>
In this analysis, we delve into the analyst ratings and average 1-year price targets of and Walgreens Boots Alliance, three key industry players, offering insights into their relative performance expectations and market positioning.
<h3>Peer Metrics Summary</h3>
The peer analysis summary provides a snapshot of key metrics for and Walgreens Boots Alliance, illuminating their respective standings within the industry. These metrics offer valuable insights into their market positions and comparative performance.

<table>
<thead>
<tr>
<th>Company</th>
<th>Consensus</th>
<th>Revenue Growth</th>
<th>Gross Profit</th>
<th>Return on Equity</th>
</tr>
</thead>
<tbody>
<tr>
<td>Walgreens Boots Alliance</td>
<td>Neutral</td>
<td>7.50%</td>
<td>$6.78B</td>
<td>-2.60%</td>
</tr>
</tbody>
</table>

Key Takeaway:
Walgreens Boots Alliance ranks in the middle among peers for consensus rating. It is at the bottom for revenue growth. It is at the top for gross profit. It is at the bottom for return on equity.
<h3>Get to Know Walgreens Boots Alliance Better</h3>
Walgreens Boots Alliance is one of the largest retail pharmacy chains in the US, with over 8,000 locations. Nearly three quarters of Americans live within five miles of a Walgreens location. Roughly two thirds of revenue is generated from prescription drug sales; Walgreens makes up 20% of total prescription revenue in the US. Walgreens also generates sales from retail products (general wellness consumables and its own branded merchandise), European drug wholesale, and healthcare. With more locations incorporating additional services like Health Corner and Village Medical, Walgreens creates an omnichannel experience for patients and positions itself as a one-stop healthcare provider.
<h3>Walgreens Boots Alliance's Economic Impact: An Analysis</h3>
Market Capitalization Analysis: Above industry benchmarks, the company's market capitalization emphasizes a noteworthy size, indicative of a strong market presence.
Revenue Growth: Over the 3 months period, Walgreens Boots Alliance showcased positive performance, achieving a revenue growth rate of 7.5% as of 30 November, 2024. This reflects a substantial increase in the company's top-line earnings. As compared to its peers, the company achieved a growth rate higher than the average among peers in Consumer Staples sector.
Net Margin: Walgreens Boots Alliance's net margin is impressive, surpassing industry averages. With a net margin of -0.67%, the company demonstrates strong profitability and effective cost management.
Return on Equity (ROE): Walgreens Boots Alliance's ROE stands out, surpassing industry averages. With an impressive ROE of -2.6%, the company demonstrates effective use of equity capital and strong financial performance.
Return on Assets (ROA): The company's ROA is a standout performer, exceeding industry averages. With an impressive ROA of -0.33%, the company showcases effective utilization of assets.
Debt Management: With a high debt-to-equity ratio of 3.09, Walgreens Boots Alliance faces challenges in effectively managing its debt levels, indicating potential financial strain.
<a href="https://www.benzinga.com/quote/WBA/earnings">To track all earnings releases for Walgreens Boots Alliance visit their earnings calendar on our site.</a>
This article was generated by Benzinga's automated content engine and reviewed by an editor.

Walgreens Boots Alliance Earnings Preview

Press Releases

SHAREHOLDER INVESTIGATION: Halper Sadeh LLC Investigates ICAD, WBA, RDW on Behalf of Shareholders

Walgreens Debuts PharmStart to Strengthen the Tech to Pharmacist Pipeline

Walgreens Committed to Supporting Rite Aid Customers and Employees

U.S. Heating Pads Market Report 2023-2029: Bear Down Brands, LLC., Beurer and Conair LLC are the Major Stakeholders – Focus Report Store

Walgreens Expands Micro-Fulfillment Network with New Facility in Brooklyn Park, Minnesota

Synergy CHC Corp. (NASDAQ: SNYR) Taps Beverage Veteran to Drive FOCUSfactor's Drink Expansion – More Stocks Inside

Synergy CHC Corp. (NASDAQ: SNYR) Restructures Debt with $20M Facility to Power Global Growth and FOCUSfactor Beverage Expansion

Synergy CHC (NASDAQ: SNYR) Taps Coca-Cola Exec to Accelerate Global Expansion of "FOCUSfactor®" Energy Drink – More Stocks Moving Inside

LiveRamp and Walgreens Advertising Group Deliver Business Growth for Advertisers Through Robust Data Collaboration Partnership

Walgreens and KFF's Greater Than Campaign to Offer Free HIV/STD Testing in Stores on June 27

ALZN

BAOS

CLRB

COST

EVGN

HTCR

ICAD

KLTO

MGNX

MODV

NAOV

NCEW

PLUG

PNPNF

RAMP

SNYR

TSXV:PNPN

WINT

Guardian Pharmacy Services, Inc. Class A Common Stock

Guardian Pharmacy Service

Mangoceuticals

Ridgetech

Deutsche Bank

Truist Securities

RBC Capital

Evercore ISI Group

B of A Securities

Screenshot 2025-03-18 at 5.59.12 PM

Fintech news covering the emerging Financial Technology services sector

Fintech

AMOD

VSBGF

Alpha Modus: Helping Set IP Leadership Standards And Usher In A New Era Of Innovation In Retail AI

Screenshot 2025-02-21 at 6.41.09 PM

Emerging Markets

Movers & Shakers

From Innovating To Protecting Its Shareholders: Alpha Modus&#39;s Strategy To Transform The Retail Market

Comments

Walgreens Boots Alliance

Actualités

Dernières nouvelles pour Walgreens Boots Alliance (NASDAQ:WBA) Stock

Les gens regardent aussi

Notizie

PARTENAIRE / CONTRIBUTEUR

BENZINGA MONDIAL